Nir Barzilai
Director of the Institute for Aging Research, Albert Einstein College of Medicine
Nir Barzilai is a physician and professor of medicine and genetics at Albert Einstein College of Medicine in New York, where he directs the Institute for Aging Research. He studies the genetics of centenarians and leads TAME, a planned trial of metformin to test whether a drug can delay aging. He wrote the 2020 book Age Later.
Updated November 1, 2026 · 1 experiment · cited in 1 guide
What Nir Barzilai has tried
1 experiment we can source: 1 kept. Trying something is not recommending it; each entry says which.
Kept
MetforminDrugs
Started 2013 · Does not recommend it to others
Has taken it off-label for about 10 years without diabetes or prediabetes, because he believes it targets aging; he leads the planned TAME trial to test that.
“We know that it targets aging”
Fortune, Reverse aging drugs may already be on pharmacy shelves (February 2023) · Status checked February 23, 2023 · Suggest a correction
Where our guides cite Nir Barzilai
Their public positions, summarized in our words. Follow each link for the full context.
Blueprint (Bryan Johnson)Oppose or doubt it
Says Johnson's choices are grounded in biology but not in clinical evidence, and that a single self-experimenter cannot produce science.